down arrow

Ajanta Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE031B01049
  • NSEID: AJANTPHARM
  • BSEID: 532331
INR
2,626.60
0.35 (0.01%)
BSENSE

Dec 05

BSE+NSE Vol: 2.84 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
1,353.73
1,302.65
1,170.41
1,146.13
1,186.64
1,144.92
1,054.08
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,353.73
1,302.65
1,170.41
1,146.13
1,186.64
1,144.92
1,054.08
Raw Material Cost
217.60
207.08
190.96
210.14
207.09
238.41
259.03
Purchase of Finished goods
53.26
51.63
80.18
78.55
45.79
45.28
40.44
(Increase) / Decrease In Stocks
45.95
17.17
12.28
-30.88
8.80
-15.84
-35.09
Employee Cost
317.01
302.90
279.78
265.17
260.96
283.78
233.51
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
392.08
372.52
310.06
302.32
352.83
262.94
277.87
Total Expenditure (Excl Depreciation)
1,025.90
951.30
873.26
825.30
875.47
814.57
775.76
Operating Profit (PBDIT) excl Other Income
327.83
351.35
297.15
320.83
311.17
330.35
278.32
Other Income
59.34
26.33
18.11
30.44
19.48
26.47
35.50
Operating Profit (PBDIT)
387.17
377.68
315.26
351.27
330.65
356.82
313.82
Interest
3.39
5.26
6.07
7.91
6.02
0.73
1.53
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
383.78
372.42
309.19
343.36
324.63
356.09
312.29
Depreciation
42.97
41.29
39.78
35.97
34.39
33.97
34.25
Profit Before Tax
340.81
331.13
269.41
307.39
290.24
322.12
278.04
Tax
80.62
75.79
44.15
74.51
73.76
76.35
75.32
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
260.19
255.34
225.26
232.88
216.48
245.77
202.72
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
260.19
255.34
225.26
232.88
216.48
245.77
202.72
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
260.19
255.34
225.26
232.88
216.48
245.77
202.72
Equity Capital
25.07
25.07
25.07
25.07
25.07
25.07
25.27
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
20.76
20.37
17.97
18.58
17.27
19.61
16.04
Diluted Earnings per share
20.82
20.43
18.0
18.59
17.26
19.53
16.09
Operating Profit Margin (Excl OI)
24.22%
26.97%
25.39%
27.99%
26.22%
28.85%
26.4%
Gross Profit Margin
28.35%
28.59%
26.42%
29.96%
27.36%
31.1%
29.63%
PAT Margin
19.22%
19.6%
19.25%
20.32%
18.24%
21.47%
19.23%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is 14.08% vs 15.38% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is 20.19% vs 10.84% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 5.35% vs 7.06% in Sep 2024

stock-summary

Interest

YoY Growth in quarter ended Sep 2025 is -43.69% vs 157.26% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024

Compare Quarterly Results Of Ajanta Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,353.73
2,556.50
-1,202.77
-47.05%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,353.73
2,556.50
-1,202.77
-47.05%
Raw Material Cost
217.60
569.87
-352.27
-61.82%
Purchase of Finished goods
53.26
126.83
-73.57
-58.01%
(Increase) / Decrease In Stocks
45.95
84.94
-38.99
-45.90%
Employee Cost
317.01
537.94
-220.93
-41.07%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
392.08
692.00
-299.92
-43.34%
Total Expenditure (Excl Depreciation)
1,025.90
2,011.58
-985.68
-49.00%
Operating Profit (PBDIT) excl Other Income
327.83
544.92
-217.09
-39.84%
Other Income
59.34
27.86
31.48
112.99%
Operating Profit (PBDIT)
387.17
572.78
-185.61
-32.41%
Interest
3.39
19.61
-16.22
-82.71%
Exceptional Items
0.00
-58.26
58.26
100.00%
Gross Profit (PBDT)
383.78
494.91
-111.13
-22.45%
Depreciation
42.97
103.33
-60.36
-58.41%
Profit Before Tax
340.81
391.58
-50.77
-12.97%
Tax
80.62
108.08
-27.46
-25.41%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
260.19
283.50
-23.31
-8.22%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
260.19
283.50
-23.31
-8.22%
Share in Profit of Associates
0.00
-2.97
2.97
100.00%
Minority Interest
0.00
-2.04
2.04
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
260.19
282.57
-22.38
-7.92%
Equity Capital
25.07
25.37
-0.30
-1.18%
Face Value
2.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
20.76
11.14
9.62
86.36%
Diluted Earnings per share
20.82
11.14
9.68
86.89%
Operating Profit Margin (Excl OI)
24.22%
21.32%
0.00
2.90%
Gross Profit Margin
28.35%
19.36%
0.00
8.99%
PAT Margin
19.22%
11.09%
0.00
8.13%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,353.73 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 3.92% vs 11.30% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 14.08% vs 15.38% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 260.19 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 1.90% vs 13.35% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 20.19% vs 10.84% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 327.83 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -6.69% vs 18.24% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 5.35% vs 7.06% in Sep 2024

Quarterly - Interest
Interest 3.39 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -35.55% vs -13.34% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -43.69% vs 157.26% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 24.22%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."